Marcus Dahlman

Marcus Dahlman has a diverse work experience spanning over 20 years. Marcus is currently the Head of Market Access Europe at Hansa Biopharma AB (publ) since July 2019. Previously, Marcus worked at Teva Pharmaceuticals, where they held the positions of Market Access Director from September 2018 to June 2019 and Nordic Head of Market Access from August 2015 to June 2019. Prior to that, they worked at Biogen Idec as an Associate Director for Global Market Access from June 2012 to August 2015 and as a Senior Health Economics Manager for the Nordic region from September 2006 to June 2012. Marcus also has experience as a Management Consultant at Dahlman Consulting from June 2003 to December 2006, as a Strategy Consultant at Destinct Consulting AB from June 2001 to June 2003, and as a Management Consultant at Resco AB from December 1999 to April 2001. Marcus started their career in 1997 as a Management Consultant at IMPAC® Integrated Control Systems, Inc., where they worked until November 1999.

Marcus Dahlman's education history begins with their attendance at Furulundsskolan. However, no specific details about the degree or field of study are provided for this period. Following that, they enrolled at Lund University from 1991 to 1995, where they earned a Bachelor of Science degree in Business Administration with a focus on Marketing and Organization. After that, from 1997 to 1998, Marcus pursued an MBA at Abertay University, specializing in International Business, Marketing, and IT. Moving forward, in 2007, they attended the University of York for a brief period to study Advanced Methods for Cost-Effectiveness Analysis, specifically focusing on the Socio Economic Evaluation of Medicines. Later, in 2008, they briefly attended the European School of Health Economics, though no specific details regarding their degree or field of study are mentioned.